Performance Evaluation of 2D Fingerprint and 3D Shape Similarity Methods in Virtual Screening
暂无分享,去创建一个
Guixia Liu | Yun Tang | Weihua Li | Guoping Hu | Wen Xiao | Guanglin Kuang | Weihua Li | Guixia Liu | Yun Tang | Wen Xiao | G. Hu | Guanglin Kuang
[1] Yongbo Hu,et al. Comparison of Several Molecular Docking Programs: Pose Prediction and Virtual Screening Accuracy , 2009, J. Chem. Inf. Model..
[2] Robert P. Sheridan,et al. Comparison of Topological, Shape, and Docking Methods in Virtual Screening. , 2007 .
[3] Thomas Sander,et al. Comparison of Ligand- and Structure-Based Virtual Screening on the DUD Data Set , 2009, J. Chem. Inf. Model..
[4] Robin Taylor,et al. Comparing protein–ligand docking programs is difficult , 2005, Proteins.
[5] James G. Nourse,et al. Reoptimization of MDL Keys for Use in Drug Discovery , 2002, J. Chem. Inf. Comput. Sci..
[6] P. Willett. Searching techniques for databases of two- and three-dimensional chemical structures. , 2005, Journal of medicinal chemistry.
[7] B. Kuhn,et al. Validation and use of the MM-PBSA approach for drug discovery. , 2005, Journal of medicinal chemistry.
[8] Anthony Nicholls,et al. What do we know and when do we know it? , 2008, J. Comput. Aided Mol. Des..
[9] Qiang Zhang,et al. Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: ranking, voting, and consensus scoring. , 2006, Journal of medicinal chemistry.
[10] Zhihai Liu,et al. Comparative Assessment of Scoring Functions on a Diverse Test Set , 2009, J. Chem. Inf. Model..
[11] J. Andrew Grant,et al. Small Molecule Shape-Fingerprints , 2005, J. Chem. Inf. Model..
[12] Iosif I Vaisman,et al. New method for protein secondary structure assignment based on a simple topological descriptor , 2005, Proteins.
[13] Tudor I. Oprea,et al. Is There a Difference Between Leads and Drugs? A Historical Perspective. , 2001 .
[14] Andreas Bender,et al. How Similar Are Similarity Searching Methods? A Principal Component Analysis of Molecular Descriptor Space , 2009, J. Chem. Inf. Model..
[15] C. E. Peishoff,et al. A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.
[16] Y. Martin,et al. Do structurally similar molecules have similar biological activity? , 2002, Journal of medicinal chemistry.
[17] John J. Irwin,et al. Community benchmarks for virtual screening , 2008, J. Comput. Aided Mol. Des..
[18] Ajay N. Jain. Bias, reporting, and sharing: computational evaluations of docking methods , 2008, J. Comput. Aided Mol. Des..
[19] Woody Sherman,et al. Rapid Shape-Based Ligand Alignment and Virtual Screening Method Based on Atom/Feature-Pair Similarities and Volume Overlap Scoring , 2011, J. Chem. Inf. Model..
[20] Piotr Cieplak,et al. Molecular dynamics and free energy analyses of cathepsin D-inhibitor interactions: insight into structure-based ligand design. , 2002, Journal of medicinal chemistry.
[21] Christine Humblet,et al. Investigation of MM-PBSA Rescoring of Docking Poses , 2008, J. Chem. Inf. Model..
[22] Andreas Zell,et al. Optimal assignment methods for ligand-based virtual screening , 2009, J. Cheminformatics.
[23] Peter Willett,et al. Similarity Searching in Databases of Three-Dimensional Chemical Structures , 1994 .
[24] John Bradshaw,et al. Similarity Searching Using Reduced Graphs , 2003, J. Chem. Inf. Comput. Sci..
[25] Jordi Mestres,et al. SHED: Shannon Entropy Descriptors from Topological Feature Distributions , 2006, J. Chem. Inf. Model..
[26] Niu Huang,et al. Physics-Based Scoring of Protein-Ligand Complexes: Enrichment of Known Inhibitors in Large-Scale Virtual Screening , 2006, J. Chem. Inf. Model..
[27] Johannes H. Voigt,et al. Cross-Docking of Inhibitors into CDK2 Structures. 2 , 2008, J. Chem. Inf. Model..
[28] Lazaros Mavridis,et al. Comprehensive Comparison of Ligand-Based Virtual Screening Tools Against the DUD Data set Reveals Limitations of Current 3D Methods , 2010, J. Chem. Inf. Model..
[29] Matthew P. Repasky,et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.
[30] G. Klebe. Virtual ligand screening: strategies, perspectives and limitations , 2006, Drug Discovery Today.
[31] Tudor I. Oprea,et al. Is There a Difference between Leads and Drugs? A Historical Perspective , 2001, J. Chem. Inf. Comput. Sci..
[32] Francesca Perruccio,et al. HPPD: Ligand- and Target-Based Virtual Screening on a Herbicide Target , 2010, J. Chem. Inf. Model..
[33] Valerie J. Gillet,et al. Further Development of Reduced Graphs for Identifying Bioactive Compounds. , 2003 .
[34] J. A. Grant,et al. A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction. , 2005, Journal of medicinal chemistry.
[35] Diane Joseph-McCarthy. Challenges of fragment screening , 2009, J. Comput. Aided Mol. Des..
[36] Ajay N. Jain,et al. Recommendations for evaluation of computational methods , 2008, J. Comput. Aided Mol. Des..
[37] J. Irwin,et al. Benchmarking sets for molecular docking. , 2006, Journal of medicinal chemistry.
[38] Hongming Wang,et al. Virtual fragment screening: an exploration of various docking and scoring protocols for fragments using Glide , 2009, J. Comput. Aided Mol. Des..
[39] Christine Humblet,et al. Chemical space sampling by different scoring functions and crystal structures , 2010, J. Comput. Aided Mol. Des..
[40] Simona Distinto,et al. Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection—What can we learn from earlier mistakes? , 2008, J. Comput. Aided Mol. Des..
[41] Wei Li,et al. Identifying Novel Molecular Structures for Advanced Melanoma by Ligand-Based Virtual Screening , 2009, J. Chem. Inf. Model..
[42] Johannes H. Voigt,et al. Cross‐Docking of Inhibitors into CDK2 Structures. Part 1. , 2008 .
[43] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[44] Robert P Sheridan,et al. Chemical similarity searches: when is complexity justified? , 2007, Expert opinion on drug discovery.
[45] Chris G. Kruse,et al. Assessment of scaffold hopping efficiency by use of molecular interaction fingerprints. , 2008, Journal of medicinal chemistry.
[46] D. Rogers,et al. Using Extended-Connectivity Fingerprints with Laplacian-Modified Bayesian Analysis in High-Throughput Screening Follow-Up , 2005, Journal of biomolecular screening.
[47] Peter Willett,et al. Similarity Searching in Files of Three-Dimensional Chemical Structures: Analysis of the BIOSTER Database Using Two-Dimensional Fingerprints and Molecular Field Descriptors , 2000, J. Chem. Inf. Comput. Sci..
[48] Paul D Lyne,et al. Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. , 2006, Journal of medicinal chemistry.
[49] Simona Distinto,et al. How To Optimize Shape-Based Virtual Screening: Choosing the Right Query and Including Chemical Information , 2009, J. Chem. Inf. Model..
[50] William L. Jorgensen,et al. Journal of Chemical Information and Modeling , 2005, J. Chem. Inf. Model..
[51] David S. Goodsell,et al. The RCSB Protein Data Bank: redesigned web site and web services , 2010, Nucleic Acids Res..
[52] Cristiano Ruch Werneck Guimarães,et al. MM-GB/SA Rescoring of Docking Poses in Structure-Based Lead Optimization , 2008, J. Chem. Inf. Model..
[53] Hege S. Beard,et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.
[54] Tudor I. Oprea,et al. Optimization of CAMD techniques 3. Virtual screening enrichment studies: a help or hindrance in tool selection? , 2008, J. Comput. Aided Mol. Des..